CAS Medical Gets FDA OK For Fore-Sight Elite In Non-Cerebral Tissue -Quick Facts

(RTTNews) - CAS Medical Systems, Inc. (CASM) said it has received approval from the U.S. Food and Drug Administration for an expanded label claim for its Fore-Sight Elite Oximeters for use in non-cerebral tissue of adults.

The approval will permit Fore-Sight Elite oximeters to be marketed to clinicians to determine oxygen saturation of hemoglobin in musculoskeletal applications, and follows CAS Medical's submission of a 510(k) application.

The company said it pans to Introduce upgraded software for this new application in the third quarter that will perfect these non-cerebral applications for the Fore-Sight Elite Oximeters.